跳至主要内容
临床试验/IRCT20180417039347N1
IRCT20180417039347N1招募中3 期

Prophylactic effect of N-acetyl-cysteine plus Atorvastatin versus N-acetyl-cysteine and Atorvastatin alone for the prevention of contrast induced nephropathy in patients undergoing elective angiography with or without percutaneous coronary intervention: a single center prospective randomized controlled trial

Zahedan University of Medical Sciences0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
21 years 至 no limit(—)
性别
All

入选标准

  • Eligible patients include individuals older than 21 years old
  • abnormal renal function (Creatinine clearance between 15 and 60 mL/min or serum creatinine (SCr) =1.1 mg/dL)
  • Undergoing elective cardiac catheterization with or without PCI

排除标准

  • Patients with end-stage renal failure (glomerular filtration rate (GFR) = 15 mL/min),
  • history of previous dialysis
  • pulmonary edema
  • emergency cardiac catheterization (patients with ST-segment elevation myocardial infarction undergoing primary PCI ),
  • exposure to contrast within previous two days ago before procedure
  • allergies to contrast media,
  • contraindication to statins
  • liver disease

研究者

发起方
Zahedan University of Medical Sciences

相似试验